Type
1.
Klis. Buruli ulcer in West Africa: Aspects of patient management. [Internet]. Vol. PhD, Medical Sciences. [Groningen]: University of Groningen; 2015. p. 199 p. Available from: http://www.rug.nl/research/portal/en/publications/buruli-ulcer-in-west-africa(c2fc1e26-e944-4e58-a706-861043f407c1).html
Type
1.
Velding, Klis, Abass, Werf, Stienstra. The application of modern dressings to Buruli ulcers: results from a pilot implementation project in Ghana. American Journal of Tropical Medicine and Hygiene [Internet]. 2016;. Available from: http://www.ajtmh.org/cgi/doi/10.4269/ajtmh.15-0378
Type
1.
Duthie MS, Balagon M. Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy. Risk management and healthcare policy [Internet]. 2016;9:43-5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854245/pdf/rmhp-9-043.pdf
Type
1.
Oliveira MBB, Diniz LM. Leprosy among children under 15 years of age: literature review. Anais brasileiros de dermatologia [Internet]. 2016;91(2):196-203. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861567/pdf/abd-91-02-0196.pdf
Type
1.
Grover S, Agale SV, D’Costa G, Valand A, Gupta VK. Clinico-histopathological spectrum of infectious granulomatous dermatoses in Western India - A representative study from Mumbai. Journal of clinical and diagnostic research : JCDR [Internet]. 2016;10(4):EC10-4. Available from: http://www.jcdr.net/articles/PDF/7568/16459_CE(Ra1)_F(GH)_PF1(SSAK)_PFA(AK)_PF2(PAG).pdf
Type
1.
Yigider AP, Kayhan FT, Yigit O, Kavak A, Cingi C. Skin diseases of the nose. American journal of rhinology & allergy. 2016;30(3):83-90.
Type
1.
Akoachere J-F, Nsai F, Ndip R. A community based study on the mode of transmission, prevention and treatment of Buruli ulcers in Southwest Cameroon: knowledge, attitude and practices. PloS one [Internet]. 2016;11(5):e0156463. Available from: http://journals.plos.org/plosone/article/asset?id=10.1371%2Fjournal.pone.0156463.PDF
Type
1.
Oliveira LFG, Pereira BAS, Gilbert B, Corrêa AL, Rocha L, Alves CR. Natural products and phytotherapy: an innovative perspective in leishmaniasis treatment. Phytochemistry Reviews. 2016;:1–15.
Type
1.
Costa S, Machado M, Cavadas C, Céu Sousa M. Antileishmanial activity of antiretroviral drugs combined with miltefosine. Parasitology research. 2016;.
Type
1.
Wasunna M, Musa A, Hailu A, Khalil E, Olobo J, Juma R, et al. The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene [Internet]. 2016;. Available from: http://trstmh.oxfordjournals.org/content/early/2016/06/07/trstmh.trw031.full.pdf+html